Holen Sie sich die Stockscreener-App
2.83
0.70%
-0.03
Schlusskurs vom Vortag:
$2.86
Offen:
$2.86
24-Stunden-Volumen:
22,552
Relative Volume:
0.02
Marktkapitalisierung:
$64.60M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-55.99M
KGV:
-1.1314
EPS:
-2.5013
Netto-Cashflow:
$-47.60M
1W Leistung:
-1.73%
1M Leistung:
-1.73%
6M Leistung:
+149.12%
1J Leistung:
+146.96%
1-Tages-Spanne:
$2.835
$2.8781
1-Wochen-Bereich:
$2.76
$2.94
52-Wochen-Spanne:
$0.9612
$3.1636
Boundless Bio Inc Stock (BOLD) Company Profile
Firmenname
Boundless Bio Inc
Sektor
Branche
Telefon
(858) 766-9912
Adresse
10955 ALEXANDRIA WAY, SAN DIEGO
Compare BOLD vs VRTX, REGN, ARGX, MRNA, RVMD
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
BOLD
Boundless Bio Inc
|
2.84 | 65.06M | 0 | -55.99M | -47.60M | -2.5013 |
VRTX
Vertex Pharmaceuticals Inc
|
521.01 | 134.06B | 12.34B | 4.34B | 3.71B | 16.87 |
REGN
Regeneron Pharmaceuticals Inc
|
802.50 | 83.43B | 14.92B | 4.42B | 3.79B | 41.04 |
ARGX
Argen X Se Adr
|
1,005.98 | 63.00B | 4.16B | 1.29B | 734.26M | 19.58 |
MRNA
Moderna Inc
|
137.18 | 56.02B | 2.23B | -3.19B | -1.60B | -8.1462 |
RVMD
Revolution Medicines Inc
|
209.52 | 44.44B | 742.00K | -1.37B | -1.07B | -7.0731 |
Boundless Bio Inc Stock (BOLD) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-06-02 | Eingeleitet | H.C. Wainwright | Buy |
| 2025-05-28 | Herabstufung | Leerink Partners | Outperform → Market Perform |
| 2024-12-13 | Herabstufung | Guggenheim | Buy → Neutral |
| 2024-04-22 | Eingeleitet | Guggenheim | Buy |
| 2024-04-22 | Eingeleitet | Leerink Partners | Outperform |
| 2024-04-22 | Eingeleitet | Piper Sandler | Overweight |
Alle ansehen
Boundless Bio Inc Aktie (BOLD) Neueste Nachrichten
Why Did BOLD, BLZE, QNT Stocks Surge To 52-Week Highs Today - Stocktwits
TANG KEVIN C Trims Boundless Bio Inc (BOLD) Stake Amid Volatile Trading - GuruFocus
Boundless Bio (NASDAQ: BOLD) Updates Serapha Merger with 19.99% Ownership Cap and Revised Voting Rules - Kalkine Media
Boundless Bio Amends Merger Agreement with Serapha Bio - TipRanks
Boundless Bio (NASDAQ: BOLD) adds $0.00001 warrants to cap ownership in Serapha deal - Stock Titan
Kevin Tang group trims Boundless Bio (BOLD) stake, returns profit - Stock Titan
2,426,857 Boundless Bio (NASDAQ: BOLD) shares held by Zachary Hornby - Stock Titan
Boundless (BOLD) Financial Update: Profit Per Share Falls Below Its Benchmark in the Reported Period - vinanet.vn
Boundless (BOLD) Session: Climbs 1.40% to $2.90 in the Current Update; Trading Range: Price Remains Between $2.75 Support and $3.04 Resistance on the DayFactor Timing - vinanet.vn
Boundless (BOLD) Results Versus Estimates: Profit Per Share Falls Below Its Benchmark in the Available Record; Shares Show Limited Movement under the Current SnapshotFiscal Year Earnings - vinanet.vn
Boundless Bio (BOLD): ADAR1 Capital discloses 8.8% beneficial ownership stake - Stock Titan
Boundless Bio (BOLD): Citadel entities and Ken Griffin report 0.6% ownership - Stock Titan
Boundless Bio (BOLD) Edges Up to $2.79 as Stock Holds Tight Trading RangeTriple Bottom - Vinanet
Boundless Bio, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 - marketscreener.com
Boundless Bio Inc (BOLD) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Boundless Bio, Inc. reports results for the quarter ended June 30Earnings Summary - TradingView
Boundless Bio, Inc. 2Q 2026: Net loss $23.7M, EPS $(1.06) — 10-Q Summary - TradingView
Boundless Bio (Nasdaq: BOLD) plans Serapha merger and dividend - Stock Titan
Boundless Bio (BOLD) Advances 3.57% to $2.90 as Support at $2.75 HoldsBPI Bull Correction - vinanet.vn
Boundless Bio, Inc. Revenue Breakdown – NASDAQ:BOLD - TradingView
Boundless Bio Inc expected to post a loss of 58 cents a shareEarnings Preview - TradingView
Boundless Bio Inc (BOLD) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Boundless Bio Inc (BOLD) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
BOLD|Boundless Bio Inc|Price:2.485|Chg%:-0.085 - TradingKey
Boundless Bio Inc (BOLD) Valuation: PE, PB & Fair Value Analysis - TradingKey
Boundless Bio Inc (BOLD) Institutional Confidence - TradingKey
Boundless Bio Inc (BOLD) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Boundless Bio Inc (BOLD) Balance Sheet - tradingkey.com
BOLD|Boundless Bio Inc|Price:2.580|Chg%:+0.010 - TradingKey
TradingKey - TradingKey
Boundless Bio Inc (BOLD) Income Statement - TradingKey
Boundless Bio Inc (BOLD) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Boundless Bio director Kevin Tang buys $11,865 in shares By Investing.com - Investing.com South Africa
Major Investor Quietly Boosts Stake in Emerging Biotech Player - TipRanks
Form 4 Boundless Bio Inc For: 21 July By Investing.com - Investing.com South Africa
Boundless Bio 10% owner Kevin Tang acquires $11,876 in common shares - Bitget
Boundless Bio director Kevin Tang buys $11,865 in shares - Investing.com
Boundless Bio (NASDAQ: BOLD) major Tang Capital holder adds 4,863 shares - Stock Titan
BOLD Q1 2026 Earnings: EPS Misses Estimates as Pre-Revenue Biotech Advances PipelineEarnings Quality Analysis - vinanet.vn
Boundless Bio Inc. (BOLD) Q1 2026 Earnings: Small EPS Miss as Pre-Revenue Clinical-Stage Biotech Reports First QuarterAnnual Earnings Summary - vinanet.vn
Boundless Bio Inc. (BOLD) Holds Near Support After Modest DeclineBuyback Factor - dars.gov.et
Tang Capital’s Kevin Tang reports $154,586 Boundless Bio common share purchase - Bitget
Boundless Bio: ten percent owner Kevin Tang buys $155,645 By Investing.com - Investing.com South Africa
Boundless Bio: ten percent owner Kevin Tang buys $155,645 - Investing.com
63,969 shares bought by Tang Capital in Boundless Bio, Inc. (BOLD) - Stock Titan
Form 4 Boundless Bio Inc For: 13 July By Investing.com - Investing.com Nigeria
Tang capital management, Kevin Tang buy $222k Boundless Bio stock By Investing.com - Investing.com Nigeria
Tang capital management, Kevin Tang buy $222k Boundless Bio stock - Investing.com
Boundless Bio (BOLD) Gains 2.45% as Shares Approach Key ResistanceRelative Volume - DonanımHaber
Kevin Tang’s Tang Capital buys $141,864 in Boundless Bio (BOLD) By Investing.com - Investing.com Nigeria
Form 4 Boundless Bio Inc For: 8 July By Investing.com - Investing.com Canada
Finanzdaten der Boundless Bio Inc-Aktie (BOLD)
Umsatz
Nettogewinn
Free Cashflow
ENV
Boundless Bio Inc-Aktie (BOLD) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| TANG KEVIN | 10% Owner |
Jul 21 '26 |
Buy |
2.44 |
2,975 |
7,259 |
2,858,935 |
| TANG KEVIN | 10% Owner |
Jul 20 '26 |
Buy |
2.44 |
1,623 |
3,960 |
2,855,960 |
| TANG KEVIN | 10% Owner |
Jul 17 '26 |
Buy |
2.44 |
265 |
647 |
2,854,337 |
| TANG KEVIN | 10% Owner |
Jul 14 '26 |
Buy |
2.43 |
43,878 |
106,624 |
2,833,981 |
| TANG KEVIN | 10% Owner |
Jul 16 '26 |
Buy |
2.44 |
18,491 |
45,118 |
2,854,072 |
| TANG KEVIN | 10% Owner |
Jul 15 '26 |
Buy |
2.44 |
1,600 |
3,904 |
2,835,581 |
| TANG KEVIN | 10% Owner |
Jul 13 '26 |
Buy |
2.42 |
48,211 |
116,671 |
2,790,103 |
| TANG KEVIN | 10% Owner |
Jul 10 '26 |
Buy |
2.43 |
43,367 |
105,382 |
2,741,892 |
| TANG KEVIN | 10% Owner |
Jul 09 '26 |
Buy |
2.48 |
7 |
17 |
2,698,525 |
| TANG KEVIN | 10% Owner |
Jul 06 '26 |
Buy |
2.49 |
27,062 |
67,384 |
2,668,370 |
0.71%
2.84%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):